Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis

被引:70
作者
Seyedmousavi, Seyedmojtaba [1 ,2 ]
Mouton, Johan W. [1 ,2 ]
Verweij, Paul E. [1 ,2 ]
Bruggemann, Roger J. M. [2 ,3 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands
[2] Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Dept Pharm, Med Ctr, NL-6525 ED Nijmegen, Netherlands
关键词
Aspergillus; azole antifungal drugs; pharmacodynamics; pharmacokinetics; therapeutic drug monitoring; POPULATION PHARMACOKINETIC ANALYSIS; EXPOSURE-RESPONSE RELATIONSHIP; IN-VITRO ACTIVITIES; AMPHOTERICIN-B; MURINE MODEL; PLASMA-CONCENTRATIONS; FUNGAL-INFECTIONS; EFFICACY; SAFETY; PROPHYLAXIS;
D O I
10.1586/14787210.2013.826989
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Voriconazole and posaconazole are extended-spectrum triazoles recommended for treatment, prophylaxis and salvage therapy of Aspergillus diseases. Over the past decade many papers have emerged supporting the use of therapeutic drug monitoring (TDM) for azole antifungals. TDM is used to tailor the exposure of a specific drug to the individuals to optimize treatment response and minimize side effects. We reviewed the pharmacokinetics and pharmacodynamics (PK-PD) characteristics of voriconazole and posaconazole. We present the available evidence on target concentrations defining maximal efficacy and minimal toxicity. Finally we provide some practical recommendations how to best perform TDM in clinical practice.
引用
收藏
页码:931 / 941
页数:11
相关论文
共 74 条
[1]   Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS [J].
Alffenaar, J. W. C. ;
Wessels, A. M. A. ;
van Hateren, K. ;
Greijdanus, B. ;
Kosterink, J. G. W. ;
Uges, D. R. A. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (01) :39-44
[2]  
[Anonymous], 2001, GUID IND BIOAN METH
[3]   In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens [J].
Barchiesi, F ;
Arzeni, D ;
Fothergill, AW ;
Di Francesco, LF ;
Caselli, F ;
Rinaldi, MG ;
Scalise, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :226-229
[4]   Pharmacokinetic changes in critical illness [J].
Boucher, Bradley A. ;
Wood, G. Christopher ;
Swanson, Joseph M. .
CRITICAL CARE CLINICS, 2006, 22 (02) :255-+
[5]   Adverse reactions to voriconazole [J].
Boyd, AE ;
Modi, S ;
Howard, SJ ;
Moore, CB ;
Keevil, BG ;
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (08) :1241-1244
[6]   Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients [J].
Bruggemann, Roger J. M. ;
Blijlevens, N. M. A. ;
Burger, David M. ;
Franke, Barbara ;
Troke, Peter F. ;
Donnelly, J. Peter .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (01) :107-113
[7]   Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents [J].
Bruggemann, Roger J. M. ;
Alffenaar, Jan-Willem C. ;
Blijlevens, Nicole M. A. ;
Billaud, Eliane M. ;
Kosterink, Jos G. W. ;
Verweij, Paul E. ;
Burger, David M. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (10) :1441-1458
[8]   International Interlaboratory Proficiency Testing Program for Measurement of Azole Antifungal Plasma Concentrations [J].
Bruggemann, Roger J. M. ;
Touw, Daan J. ;
Aarnoutse, Rob E. ;
Verweij, Paul E. ;
Burger, David M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) :303-305
[9]   Lack of Evidence for Exposure-Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections [J].
Cornely, O. A. ;
Ullmann, A. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) :351-352
[10]   Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J].
Cornely, Oliver A. ;
Maertens, Johan ;
Winston, Drew J. ;
Perfect, John ;
Ullmann, Andrew J. ;
Walsh, Thomas J. ;
Helfgott, David ;
Holowiecki, Jerzy ;
Stockelberg, Dick ;
Goh, Yeow-Tee ;
Petrini, Mario ;
Hardalo, Cathy ;
Suresh, Ramachandran ;
Angulo-Gonzalez, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :348-359